title: Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.
abstract: OBJECTIVE
  To present a case of severe drop in vision in both eyes caused by diabetic papillopathy that was treated with an intravitreal injection of triamcinolone acetonide.
  
  
  METHODS
  Interventional case report.
  
  
  METHODS
  A diabetic patient with bilateral diabetic papillopathy and drop in vision received sequential intravitreal triamcinolone acetonide injections to both eyes.
  
  
  RESULTS
  Within 2 weeks of intravitreal injection, vision improved from counting fingers at 1 m to 20/50 OS, and from counting fingers at 4 m to 20/40 OD. This improvement was accompanied by resolution of disk swelling and macular edema. Vision remained stable in both eyes at 20/40 for 8 months of follow-up. No elevation of intraocular pressure beyond 21 mm Hg was noted at any time.
  
  
  CONCLUSIONS
  Diabetic papillopathy with severe drop in vision can be treated with intravitreal triamcinolone acetonide injection.
authors.affiliation: Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon.
authors.forename: Christiane E
authors.initials: CE
authors.lastname: Al-Haddad
authors.forename: Fadi A
authors.initials: FA
authors.lastname: Jurdi
authors.forename: Ziad F
authors.initials: ZF
authors.lastname: Bashshur
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D010211:Papilledema / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014792:Visual Acuity; D014822:Vitreous Body / Q000187:drug effects
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide